Progress in understanding the human immune responses to Mycobacterium tuberculosis

Area of Science:

• Immunology
• Vaccinology
• Microbiology

Background:

• An effective tuberculosis vaccine requires a deeper understanding of the human immune response to Mycobacterium tuberculosis.
• Key immune cells and molecules, including natural killer (NK) cells and Interferon-gamma (IFN-γ), play crucial roles in combating tuberculosis.

Purpose of the Study:

• To investigate the multifaceted roles of NK cells in innate and adaptive immunity against M. tuberculosis.
• To identify transcription factors regulating IFN-γ production in response to M. tuberculosis antigens.
• To develop and evaluate a novel DNA vaccine targeting M. tuberculosis antigens for enhanced pulmonary immune responses.
• To understand the inhibitory effects of the early secreted antigenic target of 6 kDa (ESAT-6) on T-cell function.

Main Methods:

• Investigated NK cell contributions to innate and adaptive immunity, including effects on CD8+ T-cells and T regulatory cells.
• Identified transcription factors binding to the IFN-γ promoter using live T-cells activated by M. tuberculosis antigens.
• Developed a DNA vaccine encoding M. tuberculosis culture filtrate protein and lysosomal integral membrane protein-2, delivered via polyethylenimine in mice.
• Assessed vaccine-induced pulmonary immune responses and bacillary burden post-M. tuberculosis challenge.
• Studied the impact of ESAT-6 on IFN-γ production by T-cells.

Main Results:

• NK cells were shown to lyse infected phagocytes and enhance CD8+ T-cell function while inhibiting T regulatory cells.
• Three transcription factors were identified that increase IFN-γ transcription in activated T-cells.
• The novel DNA vaccine induced potent pulmonary immune responses, reducing M. tuberculosis bacillary burden by 90% in mice.
• High concentrations of ESAT-6 were found to markedly inhibit IFN-γ production by T-cells.

Conclusions:

• Enhancing NK cell functions, increasing IFN-γ transcription, and eliciting protective pulmonary immune responses are critical for tuberculosis vaccine development.
• Understanding and counteracting the inhibitory mechanisms of antigens like ESAT-6 is essential for effective vaccine design.
• These findings contribute significantly to the ongoing efforts to develop an effective antituberculosis vaccine.